Trial Profile
Aspirin Versus Clopidogrel Effect on Uterine Perfusion in Women With Unexplained Recurrent Pregnancy Loss With Decreased Uterine Artery Pulsatility Index: A Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Mar 2019
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Embolism and thrombosis; Spontaneous abortion
- Focus Pharmacodynamics
- 09 Mar 2017 Planned primary completion date changed from 1 Nov 2013 to 1 Jan 2018.
- 09 Mar 2017 Planned End Date changed from 1 Dec 2013 to 1 Mar 2018.
- 09 Mar 2017 Status changed to recruiting.